HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jin Chang Selected Research

Contrast Media

1/2019Ultrasmall bimodal nanomolecules enhanced tumor angiogenesis contrast with endothelial cell targeting and molecular pharmacokinetics.
4/2016Multifunctional reduction-responsive SPIO&DOX-loaded PEGylated polymeric lipid vesicles for magnetic resonance imaging-guided drug delivery.
8/2015Facile Synthesis of Gd-Cu-In-S/ZnS Bimodal Quantum Dots with Optimized Properties for Tumor Targeted Fluorescence/MR In Vivo Imaging.
3/2011Polymeric liposomes-coated superparamagnetic iron oxide nanoparticles as contrast agent for targeted magnetic resonance imaging of cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jin Chang Research Topics

Disease

107Neoplasms (Cancer)
01/2024 - 08/2006
6Breast Neoplasms (Breast Cancer)
12/2023 - 01/2015
6Hypoxia (Hypoxemia)
05/2021 - 01/2018
6Glioma (Gliomas)
01/2020 - 02/2009
5Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 04/2016
4Parkinson Disease (Parkinson's Disease)
01/2023 - 07/2020
4Alzheimer Disease (Alzheimer's Disease)
12/2021 - 10/2020
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 04/2014
3Colonic Neoplasms (Colon Cancer)
01/2022 - 01/2019
3Neoplasm Metastasis (Metastasis)
12/2021 - 01/2019
3Glioblastoma (Glioblastoma Multiforme)
01/2019 - 10/2012
3Brain Neoplasms (Brain Tumor)
01/2019 - 04/2010
3Carcinoma (Carcinomatosis)
01/2018 - 09/2010
2Cognitive Dysfunction
03/2024 - 01/2023
2Adenocarcinoma of Lung
12/2023 - 01/2021
2Triple Negative Breast Neoplasms
06/2023 - 01/2018
2Adenocarcinoma
01/2022 - 12/2012
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
05/2021 - 07/2019
2Hepatocellular Carcinoma (Hepatoma)
04/2020 - 01/2020
2Anaplastic Thyroid Carcinoma
01/2020 - 03/2019
2Cataract (Cataracts)
07/2019 - 01/2017
2Lung Neoplasms (Lung Cancer)
05/2017 - 09/2010
2Spinal Cord Injuries (Spinal Cord Injury)
01/2017 - 09/2010
1Iron Overload
03/2024
1Lymphoma (Lymphomas)
02/2024
1Hemangioma (Angioma)
02/2024
1B-Cell Leukemia (Leukemia, B Cell)
02/2024

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
02/2024 - 08/2006
131-phenyl-3,3-dimethyltriazene (PDT)IBA
06/2023 - 03/2014
11MicroRNAs (MicroRNA)IBA
02/2024 - 01/2018
11Liposomes (Liposome)IBA
08/2021 - 07/2008
9LipidsIBA
12/2023 - 10/2012
9Folic Acid (Vitamin M)FDA LinkGeneric
10/2022 - 05/2010
9Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2015
8Therapeutic UsesIBA
06/2022 - 04/2010
7Reactive Oxygen Species (Oxygen Radicals)IBA
11/2023 - 07/2019
7ChitosanIBA
09/2015 - 08/2006
6LigandsIBA
10/2022 - 02/2009
5Oxygen (Dioxygen)IBA
06/2021 - 01/2020
5Silicon Dioxide (Silica)FDA LinkGeneric
04/2020 - 11/2017
5ErbB Receptors (EGF Receptor)IBA
10/2019 - 04/2014
5Peptides (Polypeptides)IBA
03/2014 - 08/2006
4Photosensitizing Agents (Photosensitizers)IBA
06/2023 - 02/2016
4Indocyanine Green (Cardio-Green)FDA LinkGeneric
12/2021 - 08/2016
4AntioxidantsIBA
07/2021 - 03/2010
4Lipid NanoparticlesIBA
10/2020 - 01/2019
4Contrast MediaIBA
01/2019 - 03/2011
3IronIBA
03/2024 - 02/2009
3Glutathione (Reduced Glutathione)IBA
01/2024 - 03/2017
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2023 - 01/2020
3ProdrugsIBA
01/2023 - 01/2020
3Indicators and Reagents (Reagents)IBA
01/2023 - 05/2018
3HydrogelsIBA
12/2021 - 01/2020
3Carcinoembryonic AntigenIBA
12/2021 - 12/2017
3GoldIBA
07/2021 - 01/2018
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 04/2016
3Paclitaxel (Taxol)FDA LinkGeneric
06/2011 - 06/2010
2Messenger RNA (mRNA)IBA
01/2022 - 07/2019
2B7-H1 AntigenIBA
12/2021 - 01/2021
2Small Interfering RNA (siRNA)IBA
08/2021 - 07/2019
2AlbuminsIBA
07/2021 - 11/2016
2ParaffinIBA
05/2021 - 07/2019
2Tirapazamine (SR 4233)IBA
01/2021 - 01/2020
2astragaloside IIIIBA
01/2021 - 01/2019
2DNA (Deoxyribonucleic Acid)IBA
01/2021 - 11/2010
2PlatinumIBA
01/2021 - 04/2005
2Pancreatic Ribonuclease (Ribonuclease A)IBA
11/2019 - 04/2019
2Sorafenib (BAY 43-9006)FDA Link
10/2019 - 09/2013
2Tumor Biomarkers (Tumor Markers)IBA
04/2019 - 12/2011
2Green Fluorescent ProteinsIBA
01/2019 - 01/2018
2tungsten oxideIBA
05/2018 - 11/2017
2QuinazolinesIBA
01/2018 - 09/2013
2polycaprolactoneIBA
11/2017 - 05/2017
2Bovine Serum AlbuminIBA
11/2017 - 05/2017
2Gefitinib (Iressa)FDA Link
09/2017 - 09/2015
2IntegrinsIBA
05/2017 - 09/2015
2PolymersIBA
12/2016 - 02/2014
2ZCISIBA
10/2016 - 01/2013
2Mechlorethamine (Nitrogen Mustard)FDA Link
08/2016 - 09/2013
2Antineoplastic Agents (Antineoplastics)IBA
04/2016 - 07/2014
2Cetuximab (Erbitux)FDA Link
04/2016 - 03/2016
2LipofectamineIBA
07/2013 - 04/2010
2CholesterolIBA
09/2010 - 05/2010
2Transferrin (beta 2 Transferrin)IBA
02/2009 - 08/2006
1MetalsIBA
03/2024
1Free RadicalsIBA
03/2024
1Bleomycin (Blenoxane)FDA LinkGeneric
02/2024

Therapy/Procedure

56Therapeutics
11/2023 - 06/2010
18Drug Therapy (Chemotherapy)
01/2023 - 06/2010
10Photochemotherapy (Photodynamic Therapy)
06/2023 - 01/2015
8Precision Medicine
10/2022 - 04/2015
8Lasers (Laser)
05/2021 - 09/2010
7Photothermal Therapy
07/2021 - 08/2016
5Immunotherapy
01/2024 - 01/2021
5Quantum Dots (Quantum Dot)
07/2021 - 01/2013
4Radiotherapy
01/2020 - 04/2016
3Injections
12/2021 - 04/2016
3Microspheres (Microsphere)
01/2018 - 11/2008
3Intravenous Injections
01/2017 - 06/2010
1Sclerotherapy
02/2024